Young and Profiting | The Shocking Truth About Anne Wojcicki's 23andMe Empire @youngandprofitingpodcast | Uploaded September 2024 | Updated October 2024, 8 hours ago.
Anne Wojcicki and her co-founders started 23andMe back in 2006 with a clear mission: to make genetic testing and its results, including findings about predisposition to disease, widely available to consumers. And, in exchange for a swab of spit and a fee, 23andMe provided its customers with unprecedented insight into their own genetic make-ups. Now, Wojcicki and her company are at the forefront of a broader movement to expand personalized care and drug options in healthcare.
In today’s episode, Anne talks about the challenges in understanding the code of life, the benefits of DNA testing, concerns over privacy in the healthcare industry, and the future of medicine and new drug discovery. Anne Wojcicki is a biologist, entrepreneur and the co-founder and CEO of the personal genomics company 23andMe, which provides genetic testing for individuals curious about their ancestry and genetic makeup.
00:00 Intro
00:13 Personal Journey: From Wall Street to Healthcare
00:37 Disillusionment with the Healthcare System
00:48 Vision for a New Healthcare Community
01:24 Family Background and Early Influences
05:36 Academic and Professional Beginnings
07:41 The Profit-Driven Side of Healthcare
10:15 The Rise of Preventive Healthcare
19:52 Challenges and Controversies in Genomics
25:56 Navigating Ethical and Privacy Concerns
29:33 Educating Clinicians and Consumers
34:33 Advice for Aspiring Entrepreneurs
35:14 Transforming Genetic Testing into a Household Name
36:00 The Rise of Direct-to-Consumer Healthcare
36:50 Navigating the Challenges and Triumphs of 23andMe
39:35 The 23andMe Testing Process Explained
40:32 Discovering Ancestry and Health Insights
44:12 The Power of Genetic Research and Data Sharing
49:26 The Importance of Genetic Diversity
51:35 Heartwarming and Life-Changing Stories
57:22 The Future of Genetics and AI
01:04:41 Advice for Young Entrepreneurs
Anne Wojcicki and her co-founders started 23andMe back in 2006 with a clear mission: to make genetic testing and its results, including findings about predisposition to disease, widely available to consumers. And, in exchange for a swab of spit and a fee, 23andMe provided its customers with unprecedented insight into their own genetic make-ups. Now, Wojcicki and her company are at the forefront of a broader movement to expand personalized care and drug options in healthcare.
In today’s episode, Anne talks about the challenges in understanding the code of life, the benefits of DNA testing, concerns over privacy in the healthcare industry, and the future of medicine and new drug discovery. Anne Wojcicki is a biologist, entrepreneur and the co-founder and CEO of the personal genomics company 23andMe, which provides genetic testing for individuals curious about their ancestry and genetic makeup.
00:00 Intro
00:13 Personal Journey: From Wall Street to Healthcare
00:37 Disillusionment with the Healthcare System
00:48 Vision for a New Healthcare Community
01:24 Family Background and Early Influences
05:36 Academic and Professional Beginnings
07:41 The Profit-Driven Side of Healthcare
10:15 The Rise of Preventive Healthcare
19:52 Challenges and Controversies in Genomics
25:56 Navigating Ethical and Privacy Concerns
29:33 Educating Clinicians and Consumers
34:33 Advice for Aspiring Entrepreneurs
35:14 Transforming Genetic Testing into a Household Name
36:00 The Rise of Direct-to-Consumer Healthcare
36:50 Navigating the Challenges and Triumphs of 23andMe
39:35 The 23andMe Testing Process Explained
40:32 Discovering Ancestry and Health Insights
44:12 The Power of Genetic Research and Data Sharing
49:26 The Importance of Genetic Diversity
51:35 Heartwarming and Life-Changing Stories
57:22 The Future of Genetics and AI
01:04:41 Advice for Young Entrepreneurs
